168 related articles for article (PubMed ID: 38848538)
1. How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction.
McMullin MF; Harrison CN
Blood; 2024 Jun; ():. PubMed ID: 38848538
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.
Crodel CC; Jentsch-Ullrich K; Reiser M; Jacobasch L; Sauer A; Tesch H; Ulshöfer T; Wunschel R; Palandri F; Heidel FH
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2693-2705. PubMed ID: 34807311
[TBL] [Abstract][Full Text] [Related]
3. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
Tefferi A; Barbui T
Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
[TBL] [Abstract][Full Text] [Related]
4. Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database.
Rippel N; Tremblay D; Zubizarreta N; Podoltsev N; Gotlib J; Heaney M; Kuykendall A; O'Connell C; Shammo JM; Fleischman A; Kremyanskaya M; Hoffman R; Mesa R; Yacoub A; Mascarenhas J
Leuk Res; 2022 Aug; 119():106903. PubMed ID: 35717689
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloproliferative disorders.
Spivak JL; Barosi G; Tognoni G; Barbui T; Finazzi G; Marchioli R; Marchetti M
Hematology Am Soc Hematol Educ Program; 2003; ():200-24. PubMed ID: 14633783
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?
Mancuso S; Santoro M; Accurso V; Agliastro G; Raso S; Di Piazza F; Perez A; Bono M; Russo A; Siragusa S
Oncol Res Treat; 2020; 43(10):526-530. PubMed ID: 32772025
[TBL] [Abstract][Full Text] [Related]
7. Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?
Nazha A; Khoury JD; Verstovsek S; Daver N
Crit Rev Oncol Hematol; 2016 Sep; 105():112-7. PubMed ID: 27401783
[TBL] [Abstract][Full Text] [Related]
8. Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?
Nazha A; Gerds AT
Oncologist; 2016 Apr; 21(4):475-80. PubMed ID: 26975864
[TBL] [Abstract][Full Text] [Related]
9. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
Tefferi A; Barbui T
Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
[TBL] [Abstract][Full Text] [Related]
10. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Triguero A; Pedraza A; Pérez-Encinas M; Mata-Vázquez MI; Vélez P; Fox L; Gómez-Calafat M; García-Delgado R; Gasior M; Ferrer-Marín F; García-Gutiérrez V; Angona A; Gómez-Casares MT; Cuevas B; Martínez C; Pérez R; Raya JM; Guerrero L; Murillo I; Bellosillo B; Hernández-Boluda JC; Sanz C; Álvarez-Larrán A;
Ann Hematol; 2022 Oct; 101(10):2231-2239. PubMed ID: 36042023
[TBL] [Abstract][Full Text] [Related]
11. Cytoreduction for ET and PV: who, what, when, and how?
Tremblay D
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):660-666. PubMed ID: 38066871
[TBL] [Abstract][Full Text] [Related]
12. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.
Tefferi A; Barbui T
Am J Hematol; 2020 Dec; 95(12):1599-1613. PubMed ID: 32974939
[TBL] [Abstract][Full Text] [Related]
13. Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?
Sankar K; Stein BL
J Natl Compr Canc Netw; 2018 Dec; 16(12):1539-1545. PubMed ID: 30545998
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia Vera (PV): Update on Emerging Treatment Options.
Benevolo G; Vassallo F; Urbino I; Giai V
Ther Clin Risk Manag; 2021; 17():209-221. PubMed ID: 33758507
[TBL] [Abstract][Full Text] [Related]
15. Novel Therapies in Polycythemia Vera.
Tremblay D; Mascarenhas J
Curr Hematol Malig Rep; 2020 Apr; 15(2):133-140. PubMed ID: 32034662
[TBL] [Abstract][Full Text] [Related]
16. [Survival and prognosis of patients with polycythemia vera: a study of 816 patients in a single Chinese center].
Bai J; Shi H; Ai L; Zhang L; Zhou Y; Li Z; Zhao Y; Sheng M; Li D; Li H; Qian L; Mi Y; Xiao Z; Zheng Y; Yang R; Xue Y
Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1364-8. PubMed ID: 26178350
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in polycythemia vera treatment].
Edahiro Y
Rinsho Ketsueki; 2020; 61(9):1187-1194. PubMed ID: 33162515
[TBL] [Abstract][Full Text] [Related]
18. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Alvarez-Larrán A; Garrote M; Ferrer-Marín F; Pérez-Encinas M; Mata-Vazquez MI; Bellosillo B; Arellano-Rodrigo E; Gómez M; García R; García-Gutiérrez V; Gasior M; Cuevas B; Angona A; Gómez-Casares MT; Martínez CM; Magro E; Ayala R; Del Orbe-Barreto R; Pérez-López R; Fox ML; Raya JM; Guerrero L; García-Hernández C; Caballero G; Murillo I; Xicoy B; Ramírez MJ; Carreño-Tarragona G; Hernández-Boluda JC; Pereira A;
Cancer; 2022 Jul; 128(13):2441-2448. PubMed ID: 35417564
[TBL] [Abstract][Full Text] [Related]
19. Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.
Mora B; Guglielmelli P; Kuykendall A; Rumi E; Maffioli M; Palandri F; De Stefano V; Caramella M; Salmoiraghi S; Kiladjian JJ; Gotlib J; Iurlo A; Cervantes F; Ruggeri M; Silver RT; Albano F; Benevolo G; Ross DM; Della Porta MG; Devos T; Rotunno G; Komrokji RS; Casetti IC; Merli M; Brociner M; Caramazza D; Auteri G; Barbui T; Cattaneo D; Bertù L; Arcaini L; Vannucchi AM; Passamonti F
Leukemia; 2022 Oct; 36(10):2453-2460. PubMed ID: 36042316
[TBL] [Abstract][Full Text] [Related]
20. Givinostat: an emerging treatment for polycythemia vera.
Chifotides HT; Bose P; Verstovsek S
Expert Opin Investig Drugs; 2020 Jun; 29(6):525-536. PubMed ID: 32693648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
